This inventor holds 1 USPTO granted patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 1976.
Company Filing History:
Years Active: 1976
Title: Junzo Matumoto: Innovator in Metabolic Disorder Treatments
Introduction
Junzo Matumoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of metabolic disorders. His innovative work has led to the development of compounds that are useful for prophylaxis and therapy in various health conditions.
Latest Patents
Junzo Matumoto holds a patent for N-(mercaptoacyl)aminoacids. This patent describes compounds that are beneficial in treating metabolic disorders, such as nosotoxicosis due to heavy metal radiation disorder, diabetes, or hepatitis. The patent also includes intermediates that are essential for the synthesis of these compounds.
Career Highlights
Matumoto is associated with Santen Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in therapeutic solutions. His work has garnered attention for its potential impact on public health.
Collaborations
Throughout his career, Junzo Matumoto has collaborated with esteemed colleagues, including Itaru Mita and Shigeo Okumura. These partnerships have fostered innovation and have contributed to the success of his research endeavors.
Conclusion
Junzo Matumoto's contributions to the field of medicine through his patent and collaborative efforts highlight his role as an innovator in the treatment of metabolic disorders. His work continues to inspire advancements in therapeutic solutions.